Stalevo

In the US, Stalevo (carbidopa/entacapone/levodopa systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease.

US matches:

• Stalevo


• Stalevo 100


• Stalevo 125


• Stalevo 150


• Stalevo 200


• Stalevo 50


• Stalevo 75

UK matches:

• Stalevo 100/25/200mg
• Stalevo 125/31.25/200mg
• Stalevo 150/37.5/200mg
• Stalevo 200/50/200mg
• Stalevo 50/12.5/200mg
• Stalevo 75/18.75/200mg
• Stalevo 100/25/200mg (SPC)
• Stalevo 125/31.25/200mg (SPC)
• Stalevo 150/37.5/200mg (SPC)
• Stalevo 200/50/200mg (SPC)
• Stalevo 50/12.5/200mg (SPC)
• Stalevo 75/18.75/200mg (SPC)

Ingredient matches for Stalevo

Carbidopa

Carbidopa is reported as an ingredient of Stalevo in the following countries:

• Austria


• Brazil


• Czech Republic


• Denmark


• Germany


• Indonesia


• Netherlands


• Norway


• Oman


• Singapore


• South Africa


• Sweden


• Taiwan


• Thailand


• United Kingdom


• United States

Carbidopa monohydrate (a derivative of Carbidopa) is reported as an ingredient of Stalevo in the following countries:

• Switzerland

Entacapone

Entacapone is reported as an ingredient of Stalevo in the following countries:

• Austria


• Brazil


• Czech Republic


• Denmark


• Germany


• Indonesia


• Netherlands


• Norway


• Oman


• Singapore


• South Africa


• Sweden


• Switzerland


• Taiwan


• Thailand


• United Kingdom


• United States

Levodopa

Levodopa is reported as an ingredient of Stalevo in the following countries:

• Austria


• Brazil


• Czech Republic


• Denmark


• Germany


• Indonesia


• Netherlands


• Norway


• Oman


• Singapore


• South Africa


• Sweden


• Switzerland


• Taiwan


• Thailand


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.